Biodistribution of negatively charged iron oxide nanoparticles (IONPs) in mice and enhanced brain delivery using lysophosphatidic acid (LPA)

Wegscheid, 2014, The art of attraction: Applications of multifunctional magnetic nanomaterials for malignant glioma, Expert Opin Drug Deliv, 11, 957, 10.1517/17425247.2014.912629 Costantino, 2014, Challenges in the design of clinically useful brain-targeted drug nanocarriers, Curr Med Chem, 21, 4227, 10.2174/0929867321666140716101921 On, 2013, Examination of blood–brain barrier (BBB) integrity in a mouse brain tumor model, J Neurooncol, 111, 133, 10.1007/s11060-012-1006-1 Zhang, 2004, Plasma membrane localization of multidrug resistance-associated protein homologs in brain capillary endothelial cells, J Pharmacol Exp Ther, 311, 449, 10.1124/jpet.104.068528 Xin, 2012, The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles, Biomaterials, 33, 1673, 10.1016/j.biomaterials.2011.11.018 Zhang, 2012, Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: Synthesis, preparation and in vivo evaluation, J Control Release, 159, 429, 10.1016/j.jconrel.2012.01.031 Kuo, 2012, Transcytosis of CRM197-grafted polybutylcyanoacrylate nanoparticles for delivering zidovudine across human brain-microvascular endothelial cells, Colloids Surf B: Biointerfaces, 91, 242, 10.1016/j.colsurfb.2011.11.007 Prados, 2003, A randomized, double-blind, placebo-controlled, phase 2 study of RMP-7 in combination with carboplatin administered intravenously for the treatment of recurrent malignant glioma, Neuro Oncol, 5, 96, 10.1093/neuonc/5.2.96 Sun, 2014, Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood–brain barrier, Int J Nanomedicine, 9, 3013, 10.2147/IJN.S62260 Aryal, 2014, Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous system, Adv Drug Deliv Rev, 72, 94, 10.1016/j.addr.2014.01.008 On, 2013, Rapid and reversible enhancement of blood–brain barrier permeability using lysophosphatidic acid, J Cereb Blood Flow Metab, 33, 1944, 10.1038/jcbfm.2013.154 Tomsig, 2009, Lipid phosphate phosphohydrolase type 1 (LPP1) degrades extracellular lysophosphatidic acid in vivo, Biochem J, 419, 611, 10.1042/BJ20081888 Yathindranath, 2013, One-pot synthesis of iron oxide nanoparticles with functional silane shells: A versatile general precursor for conjugations and biomedical applications, Langmuir, 29, 10850, 10.1021/la402007d Yathindranath, 2011, A versatile method for the reductive, one-pot synthesis of bare, hydrophilic and hydrophobic magnetite nanoparticles, Adv Funct Mater, 21, 1457, 10.1002/adfm.201002111 Triguero, 1990, Capillary depletion method for quantification of blood–brain barrier transport of circulating peptides and plasma proteins, J Neurochem, 54, 1882, 10.1111/j.1471-4159.1990.tb04886.x Luft, 1961, Improvements in epoxy resin embedding methods, J Biophys Biochem Cytol, 9, 409, 10.1083/jcb.9.2.409 Sun, 2013, Characterization of cellular uptake and toxicity of aminosilane-coated iron oxide nanoparticles with different charges in central nervous system-relevant cell culture models, Int J Nanomedicine, 8, 961, 10.2147/IJN.S39048 Li, 1788, Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer, Biochim Biophys Acta, 2009, 2259 Chao, 2012, Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains, Bioconjug Chem, 23, 1003, 10.1021/bc200685a Patel, 2012, Polymeric nanoparticles for drug delivery to the central nervous system, Adv Drug Deliv Rev, 64, 701, 10.1016/j.addr.2011.12.006 Kang, 2014, iNGR-modified PEG-PLGA nanoparticles that recognize tumor vasculature and penetrate gliomas, Biomaterials, 35, 4319, 10.1016/j.biomaterials.2014.01.082 Kroll, 1998, Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: A comparison of osmotic versus bradykinin modification of the blood–brain and/or blood-tumor barriers, Neurosurgery, 43, 879, 10.1097/00006123-199810000-00090 Rousseau, 1997, Investigation of blood–brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats, MAGMA, 5, 213, 10.1007/BF02594584 Bellavance, 2008, Recent advances in blood–brain barrier disruption as a CNS delivery strategy, AAPS J, 10, 166, 10.1208/s12248-008-9018-7 Maeda, 2012, Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting, Proc Jpn Acad Ser B Phys Biol Sci, 88, 53, 10.2183/pjab.88.53 Schleich, 2014, Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy, J Control Release, 194, 82, 10.1016/j.jconrel.2014.07.059 Nakamura, 2015, Development of next-generation macromolecular drugs based on the EPR effect: Challenges and pitfalls, Expert Opin Drug Deliv, 12, 53, 10.1517/17425247.2014.955011 Ke, 2009, Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer, Biomaterials, 30, 6976, 10.1016/j.biomaterials.2009.08.049 Shao, 2010, Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain, J Control Release, 147, 118, 10.1016/j.jconrel.2010.06.018 van der Meel, 2013, Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status, Adv Drug Deliv Rev, 65, 1284, 10.1016/j.addr.2013.08.012 Bertrand, 2011, Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1, Br J Cancer, 105, 1697, 10.1038/bjc.2011.427 Sun, 2011, Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles, Cell Biol Toxicol, 27, 333, 10.1007/s10565-011-9191-9 Mesarosova, 2014, The role of reactive oxygen species in the genotoxicity of surface-modified magnetite nanoparticles, Toxicol Lett, 226, 303, 10.1016/j.toxlet.2014.02.025 Magdolenova, 2015, Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles, Nanotoxicology, 9, 44, 10.3109/17435390.2013.847505 Li, 2009, Glia activation induced by peripheral administration of aluminum oxide nanoparticles in rat brains, Nanomedicine, 5, 473, 10.1016/j.nano.2009.01.013 De Astis, 2013, Nanostructured TiO2 surfaces promote polarized activation of microglia, but not astrocytes, toward a proinflammatory profile, Nanoscale, 5, 10963, 10.1039/c3nr03534d Albertazzi, 2013, In vivo distribution and toxicity of PAMAM dendrimers in the central nervous system depend on their surface chemistry, Mol Pharm, 10, 249, 10.1021/mp300391v Cupaioli, 2014, Engineered nanoparticles. How brain friendly is this new guest?, Prog Neurobiol, 119–120, 20, 10.1016/j.pneurobio.2014.05.002 Laksitorini, 2015, Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood–brain barrier permeability, J Pharm Sci, 104, 1065, 10.1002/jps.24309 Worden, 2015, Aqueous synthesis of polyhedral "brick-like" iron oxide nanoparticles for hyperthermia and T2 MRI contrast enhancement, J Mater Chem B, 3, 6877, 10.1039/C5TB01138H